An exam candidate who hears propranolol called an “anti-tremor pill” may wonder whether it could help with nerves or performance. But it should not be treated as a medicine for doing better on a test. South Korea's Ministry of Food and Drug Safety (MFDS) and the Korea Institute of Drug Safety & Risk Management (KIDS) released safe-use information on October 22, 2026, ahead of the 2027 academic-year college entrance exam. MFDS's central message is that there is no medicine that makes someone perform well on an exam. The notice does not negate legitimate prescriptions. It cautions, in particular, against misuse aimed only at better scores when a person has no relevant symptoms.
What kind of medicine is it—and what is it not?
MFDS describes propranolol as a beta blocker that blocks sympathetic beta receptors. Its release lists treatment of cardiovascular conditions including arrhythmia, angina and high blood pressure, and identifies it in South Korea as a prescription-only medicine. “Used to treat a condition” does not mean “proven to raise a healthy student's exam score.” The notice does not present the drug as an exam-performance treatment. Another person's account of feeling less shaky does not establish that you need the medicine, that it is safe for you, or that it will improve your result.
The situation MFDS explicitly warns about is misuse solely to do better on an exam despite the absence of symptoms such as tremor or anxiety. The reverse is not an automatic permission: having tremor or anxiety does not mean you should diagnose yourself and take this medicine. A clinician must consider the person's condition and reason for use. This article cannot diagnose an individual or decide whether a particular student should receive a prescription.
What if the prescription is actually mine?
This notice is not an instruction for someone with a legitimate prescription to stop taking it abruptly. Discuss why it was prescribed, your present condition, other medicines you take and any troubling symptoms with your prescribing clinician or pharmacist. If an upcoming exam has prompted questions about your treatment, include that context in the conversation. Do not let an online summary—or another student's experience—decide whether to start, change the dose or stop. MFDS specifically asked clinicians and pharmacists to check the patient's condition and purpose of use when counseling.
Can I use a friend’s or family member’s prescription?
Do not borrow someone else's prescription medicine, even “just once” for an exam. A prescription and dispensing guidance are tied to assessment of a person's condition and purpose of use. Taking the same exam or having similar nerves does not make someone else's prescription yours. MFDS advises use only after a doctor's prescription and with a pharmacist's dispensing and medication guidance. It also asked medical institutions and pharmacies to check a patient's condition and reason for use during prescription and medication counseling. A friend's story or the name of a drug cannot replace those checks.
A person with no relevant symptoms who wants a test advantage and a person already treated for a health condition are in different situations. The first needs to heed the warning about exam-related misuse. The second should not read “not an exam drug” as a direction to change an existing treatment plan on their own. In either case, explaining the reason for use and current circumstances to a qualified professional matters.
What adverse effects did the notice name?
MFDS says drowsiness or fatigue, dizziness, orthostatic hypotension and bradycardia may occur when taking propranolol. A nickname focused on tremor leaves out that part of the official safety message. Nothing in the release promises that someone without a prescription can take it for an exam without risk. Treating an unfamiliar prescription medicine as a last-minute performance aid is not consistent with the safe-use principle in the notice. That is a caution, not a prediction of a particular person's reaction or test result.
If you have taken it and feel unwell, do not assume a symptom is harmless or use an online article to adjust your dose. Tell your prescribing clinician or pharmacist what you took, why and when, and what you have experienced, so they can advise in light of your circumstances. This article supplies no individual dose, timing or stop-treatment instruction, and the listed effects are possibilities, not outcomes for everyone.
The practical distinction
Propranolol is a prescription medicine, not an exam-score enhancer. Avoid using it solely as an exam aid without relevant symptoms, and do not use someone else's prescription. Bring questions about your own treatment to your clinician or pharmacist. This article explains the scope of the October 22, 2026 MFDS/KIDS notice; it is not a substitute for individual medical care.
Also on Naver Blog
A related Korean-language safety summary is available at Life Mokcha's Naver post.
About the Author
Life Mokcha's editor, “Mokcha Keeper,” checks original public-agency notices to clarify who is affected and what the agency actually advises.
